Therapeutic Plasma Exchange
Biological age reversal claims
Therapeutic plasma exchange (plasmapheresis) removes blood, separates plasma from cells, and returns cells with replacement fluid. It's established treatment for autoimmune conditions. But longevity clinics now market it for anti-aging—claiming to remove "pro-aging factors" and reverse epigenetic age. The science is genuinely interesting; the clinical application remains highly experimental.
The Research Foundation
Heterochronic parabiosis experiments—connecting the circulatory systems of young and old mice—showed that old mice received regenerative benefits from young blood. This sparked interest in what factors in blood affect aging. Research has identified both "pro-aging" factors that accumulate and "rejuvenating" factors that decline.
The idea behind plasma exchange for longevity is simple: remove old plasma containing accumulated pro-aging factors, replace with neutral fluid, and let the body regenerate a younger plasma composition. Some studies have shown reductions in epigenetic age markers after treatment.
Why It Matters for Luxury
Plasma exchange for longevity represents the leading edge of anti-aging medicine—genuine science rapidly translated into consumer products before outcomes are validated. Clients receive real procedures based on real research with real effects on measurable biomarkers. Whether those biomarkers translate to living longer or better remains entirely unknown.
Research
- Clinical trial and multi‑omics analysis of therapeutic plasma exchange (Buck Institute) — Aging Cell trial summary — May 2025
- Human clinical trial of plasmapheresis effects on biomarkers of aging — Epigenetic biomarker outcomes in healthy donors — July 2025